We are live on ! Find out more
ADAP

Adaptimmune Therapeutics

Delisted

ADAP was delisted on the 27th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
CG
76
Cutler Group
California
$71K +$7.34K +700 +15%
Wells Fargo
77
Wells Fargo
California
$38K -$14.7K -1,400 -33%
SPIA
78
Steward Partners Investment Advisory
New York
$27K
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$14K
KBC Group
80
KBC Group
Belgium
$13K
SMFS
81
Squar Milner Financial Services
California
$9K
RE
82
RBC Europe
United Kingdom
$8.14K
TRCT
83
Tower Research Capital (TRC)
New York
$7K -$15.4K -1,465 -75%
Bank of America
84
Bank of America
North Carolina
$6K -$36.1K -3,439 -88%
NFG
85
Next Financial Group
Texas
$6K +$4.98K +475 New
MYIA
86
Mount Yale Investment Advisors
Colorado
$6K +$8.73K +833 New
CAG
87
Csenge Advisory Group
Florida
$5K +$10.5K +1,003 New
Daiwa Securities Group
88
Daiwa Securities Group
Japan
$4K
ASN
89
Advisory Services Network
Georgia
$2K
LTFS
90
Ladenburg Thalmann Financial Services
Florida
$2K +$1.42K +135 New
ED
91
Exane Derivatives
France
$1.61K -$139K -13,251 -99%
Barclays
92
Barclays
United Kingdom
$1K -$367K -35,053 -100%
RCAG
93
Rehmann Capital Advisory Group
Michigan
$650
Lazard Asset Management
94
Lazard Asset Management
New York
-$1.91M -160,892 Closed
BBA
95
Baker Bros. Advisors
New York
-$1.19M -100,000 Closed
Arrowstreet Capital
96
Arrowstreet Capital
Massachusetts
-$815K -68,665 Closed
Squarepoint
97
Squarepoint
New York
-$596K -50,200 Closed
PA
98
Perceptive Advisors
New York
-$585K -49,302 Closed
FAM
99
Fred Alger Management
New York
-$297K -25,000 Closed
TMC
100
Trellus Management Company
Florida
-$195K -16,464 Closed